FAIRPORT HARBOR, Ohio, July 19, 2017 -- OurPet’s Company (OTCQX:OPCO) (www.ourpets.com), (the “Company” or “OurPet’s”), a leading proprietary pet supply company with over 170 patents issued or pending, plans to show off its innovative line of products at SuperZoo in Las Vegas, NV, July 25-27, 2017. SuperZoo boasts the most buyer and exhibitor participation of any trade show for the pet retail industry in North America.
“Last year’s SuperZoo was a great success with the release of our advanced Switchgrass Natural Cat Litter™ with BioChar and this year will be no different. We have been able to top ourselves with the new products we will be introducing this year,” said Rachelle Rabasi, Director of Marketing for OurPet’s. “The new technology that we will be showcasing is unlike anything that is currently on the market in the pet industry and we are excited to see the response.”
OurPet’s continues to be an innovator in the pet industry by focusing on making patent protected products that fulfill the instinctual needs of pets to strengthen the pet and pet parent bond, creating harmony in the home. OurPet’s will be exhibiting during SuperZoo 2017 at booth #3135.
For more information on the OurPet’s Company, visit www.ourpets.com.
About The OurPet’s Company:
OurPet’s Company designs, produces and markets a broad line of innovative, high-quality accessory and consumable pet products in the U.S. and overseas. Investors and customers may visit www.ourpets.com for more information about our company and its products. OurPet’s websites include www.petzonebrand.com and www.ourpets.com.
Media Contact: Peter Ostapowicz Marketing Coordinator 440-354-6500 x141 [email protected] Investor Contact: Chris Donovan or Steve Calk Alpha IR Group (312) 445-2870 [email protected]


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
FDA Approves Mitapivat for Anemia in Thalassemia Patients
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Italy Fines Apple €98.6 Million Over App Store Dominance
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



